Prussian
blue analogues (PBAs) have been highlighted as electrode
materials for aqueous rechargeable batteries (ARBs) because of their
favorable crystal structure and electrochemical activity. However,
dissolution of the transition-metal ions during cycling degrades the
materials and hinders the development of long-life-span batteries.
To overcome this limitation, a strategy to revive the capacity degradation
of PBA-based cathodes was developed herein based on designing all-PBA-based
core@shell materials, while specific reduction upon introducing the
shell layers was minimized. The core@shell materials were constructed
using a V/Fe PBA (high capacity) core and a Cu/Fe PBA (high cycling
stability) shell via a two-step co-precipitation method. The electrochemical
performances including specific capacity, cycling stability, and rate
capability as a function of the Cu/Fe PBA shell thickness were explored.
At the optimal Cu/Fe PBA thickness, improved capacity retention after
200 cycles of >90% (72% for the core only) was attained with negligible
capacity reductions from 94 (core only) to 90 (core@shell) mA h g–1, arising from the high electrochemical activity and
stability of the Cu/Fe PBA shell and stabilized interfaces due to
the crystallographic coherence between the core and shell materials.
In addition, the power performance of the core@shell materials was
significantly improved, e.g., C38.4C/C0.6C for
a core@shell of 80% and core only of 62%, arising from the unique
chemical coordination and facile ion diffusion kinetics of the Cu/Fe
PBA shell. The newly developed V/Fe@Cu/Fe PBA-based cathodes offer
an effective strategy for fabricating sustainable and low-cost ARBs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.